Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/6c02db42-433d-4918-8688-945b0edead32/

HIK

Hikma Pharmaceuticals PLC
Chart
£1,471.00
Latest Week 2026-06-05
HealthcareDrug Manufacturers - Specialty & GenericMEGA
Snapshot 2026-06-07 · 0.0w · Fresh
0.75
OS Score
82.0%
Value
71.0%
Quality
11.0%
Momentum
6/9
F-Score
0.763
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
1 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
QV 0.763
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
82.0%ile
P/E
805.4×
P/S
96.7×
P/B
124.9×
E/P
0.0012
FCF Yield
0.000
EBITDA/EV
0.003
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
17.00000000
/100 — 1=cheapest
VC2 (Trending Value)
15.00000000
/100
VC3 (Buyback)
17.00000000
/100
P/E of 805.4x is premium-priced — the market is paying up for expected growth.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
71.0%ile
ROE
0.155
ROA
0.071
Net Margin
0.120
Op Margin
0.189
GPA
0.254
Current
1.82
F-Score
6/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.071
Earn Growth
0.121
Accruals
-0.006
lower=better
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
11.0%ile
6M Return
-7.7%
12M Return
-30.8%
12-1 Mom
-33.4%
Risk-Adj
-0.96
Vol 252d
34.6%
Vol 60d
81.1%
↑ Expanding
Max DD 12M
-43.2%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of -33% signals a downtrend — price is moving against you. Near-term vol (81%) is expanding vs long-term (35%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.75
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 75 peers
Sector Value %ile
96.1%
Sector Quality %ile
82.9%
P/E z-score
-1.13
P/B z-score
-0.33
Sector Avg OS
33.1%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
BVC BATM Advanced Communications Ltd. 79.0% 64.0% 62.0% 63.0%
AVCT Avacta Group Plc 79.0% 64.0% 62.0% 63.0%
SPI Spire Healthcare Group plc 77.0% 73.0% 75.0% 29.0%
CRTX CRISM Therapeutics Corporation 75.0% 62.0% 60.0% 61.0%
CVSG CVS Group plc 74.0% 61.0% 60.0% 61.0%
CIZ Cizzle Biotechnology Holdings Plc 73.0% 61.0% 59.0% 60.0%
COIL Coiled Therapeutics plc 73.0% 60.0% 59.0% 60.0%
CHLL Chill Brands Group PLC 73.0% 61.0% 59.0% 60.0%
Factor Interactions
Value + Quality Intersection
Top-tier on both cheapness (82th) and quality (71th) — the O'Shaughnessy sweet spot, historically the strongest long-term combination.
Falling Knife
Weak momentum (11th) despite looking cheap (82th value). Wait for momentum to stabilise.
Volatility Expanding
60-day vol (81%) significantly exceeds 252-day (35%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
4.0% avg (7 factors)
Quality
C
53.0% avg (7 factors)
Momentum
F
7.2% avg (4 factors)
Risk
C
59.0% avg (1 factors)
Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.750—1—
Value %ile0.820—1—
Quality %ile0.710—1—
Momentum %ile0.110—1—
F-Score6.000—0—
Confidence0.813—1—
Volatility0.346—0—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
805.42
Earnings Yield (E/P)
0.0012
Price / Sales
96.68
Price / Book
124.87
Price / Cash Flow
742.61
FCF Yield
0.0%
EBITDA / EV
0.3%
Sales Yield (1/P·S)
0.0103
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
15.5%
Return on Assets
7.1%
Net Margin
12.0%
Operating Margin
18.9%
Gross Profit / Assets
Novy-Marx GPA
25.4%
Current Ratio
1.82
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.006
MomentumPrice trend strength over different horizons
6M Return
-7.7%
12M Return
-30.8%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
-33.4%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
-0.96
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
7.1%
Earnings Growth (YoY)
12.1%
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
6
Dividend Yield
0.1%
Buyback Yield
-0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
17
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
15
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
17
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity